Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8632999 | Metabolism | 2018 | 42 Pages |
Abstract
FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in HFD-induced obesity. FNDC5 plays several beneficial roles in obesity and may be used as a therapeutic regimen for preventing inflammation and insulin resistance in obesity and diabetes.
Keywords
SVFPGC-1αp38IL-1βP65HFDNOS2GTTRAW264.7FNDC5mTORCTRLPMSYm1Jnkfibronectin type III domain-containing protein 5LPSAICAR5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranosideJun NH2-terminal kinaseNF-κBERK1/2insulin tolerance testinflammationInterleukin-1βITTAdipose tissueWhite adipose tissuecompound Cglucose tolerance testtumor necrosis factor-αATMsHigh fat dietTNF-αnuclear factor-κBlipopolysaccharideMacrophagesadipose tissue macrophagesObesityInsulin resistancewild-typenitric oxide synthase 2mammalian target of rapamycinp38 mitogen-activated protein kinase (MAPK)WATStromal vascular fractionControlPeroxisome proliferator-activated receptor gamma coactivator-1α
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Xiao-Qing Xiong, Zhi Geng, Bing Zhou, Feng Zhang, Ying Han, Ye-Bo Zhou, Jue-Jin Wang, Xing-Ya Gao, Qi Chen, Yue-Hua Li, Yu-Ming Kang, Guo-Qing Zhu,